WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
OpenAI pauses ChatGPT voice after Scarlett Johansson comparisons
Vaccine maker becomes China's richest man after wealth increases fifty
Hong Kong man jailed 21 months for throwing eggs
Philippines blames China for loss of giant clams in disputed shoal and urges environmental inquiry
Olivia Munn's breast cancer diagnosis raising awareness for women to seek additional screening
Ministry of Ethnic Communities, set up to 'heal wounds' of 15 March, faces job cuts
Labour Party says use of Andrew Tate image in Instagram post a mistake
Travis Kelce downs whiskey shot on slice of bread at Kelce Jam without Taylor Swift
Tauranga bars to close earlier under booze rule changes
Hall of Fame outfielder Ken Griffey Jr. to lead Indianapolis 500 field in Corvette pace car
Digital declaration now available for all international travellers to NZ